4
Changes in Ownership
Armata Pharmaceuticals, Inc. Filed Acc 0001104659-20-133644
Options or other derivatives
- Chief Executive Officer acquired 23,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patrick Todd Chief Executive Officer | 2020-12-08 | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | D: show line 1 in the form |
Loading xslF345X03/tm2038059-11_4seq1.xml…